Clearance of intracellular Klebsiella pneumoniae infection using gentamicin-loaded nanoparticles

Research output: Contribution to journalArticlepeer-review

41 Citations (Scopus)
683 Downloads (Pure)


Klebsiella pneumoniae is a foremost gram-negative pathogen that can induce life-threatening nosocomial pulmonary infections. Although it can be phagocytosed successfully by lung resident macrophages, this pathogen remains viable within vacuolar compartments, resulting in chronic infection and limiting therapeutic treatment with antibiotics. In this study, we aimed to generate and evaluate a cell-penetrant antibiotic poly( lactide- co- glycolide) (PLGA)-based formulation that could successfully treat intracellular K. pneumoniae infection. Screening of formulation conditions allowed the generation of high drug entrapment nanoparticles through a water-in-oil-in-water approach. We demonstrated the therapeutic usefulness of these gentamicin-loaded nanoparticles (GNPs), showing their ability to improve survival and provide extended prophylactic protection towards K. pneumoniae using a Galleria mellonella infection model. We subsequently showed that the GNPs could be phagocytosed by K. pneumoniae infected macrophages, and significantly reduce the viability of the intracellular bacteria without further stimulation of pro-inflammatory or pro-apoptotic effects on the macrophages. Taken together, these results clearly show the potential to use antibiotic loaded NPs to treat intracellular K. pneumoniae infection, reducing bacterial viability without concomitant stimulation of inflammatory or pyroptotic pathways in the treated cells.
Original languageEnglish
Pages (from-to)316
JournalJournal of Controlled Release
Early online date25 Apr 2018
Publication statusEarly online date - 25 Apr 2018


Dive into the research topics of 'Clearance of intracellular Klebsiella pneumoniae infection using gentamicin-loaded nanoparticles'. Together they form a unique fingerprint.

Cite this